Company: SVREW
Filing Date: 2025-03-31
Form Type: F-1
Source: 0001213900-25-026309
Chunk: 3

Company: SaverOne 2014 Ltd.
Filing Date: 2025-03-31
Form: F-1
Chunk 3
---
 (the “2024 Reverse Stock Split”, and collectively with the 2025 Reverse Stock Split, the “Reverse Stock Splits”). Our Ordinary Shares were unaffected by the new exchange ratio for ADSs. Our ADSs are evidenced by American Depositary Receipts, or “ADRs.”

Unless noted otherwise, all ADSs and the price per ADS numbers for all periods presented in this prospectus have been retroactively adjusted for the Reverse Stock Splits.

The Selling Shareholders may sell the ADSs offered by this prospectus from time to time on terms to be determined at the time of sale through ordinary brokerage transactions or through any other means described in this prospectus under the caption “Plan of Distribution.” The ADSs may be sold at fixed prices, at market prices prevailing at the time of sale, at prices related to prevailing market prices or at negotiated prices.

There is no public trading market for our Investor Warrants and the Placement Agent Warrants (collectively, the “Warrants”), and we do not expect a market to develop. Also, do not intend to apply for a listing of the Warrants on any national securities exchange.

Our ordinary shares are listed
on the Tel Aviv Stock Exchange Ltd., or the TASE, under the symbol “SVRE.” The last reported sale price of our ordinary shares
on the TASE on March 30, 2025 was NIS 0.01 or $0.0027 per share (based on the exchange rate reported by the Bank of Israel on that date,
which was NIS 3.684 = $1.00).

Our ADSs are listed on the
Nasdaq Capital Market, or Nasdaq, under the symbol “SVRE. The last reported sale price of our ADSs on Nasdaq on March 28, 2025 was
$3.215 per ADS.

We may amend or supplement this prospectus from time to time by filing amendments or supplements as required. You should read this entire prospectus and any amendments or supplements carefully before you make your investment decision.

We are both an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act, and, a “foreign private issuer,” as defined under the U.S. federal securities laws, and as such, are eligible for reduced public company reporting requirements. See “Prospectus Summary—Implications of Being an Emerging Growth Company and a Foreign Private Issuer” for additional information.

Investing in our securities involves